Clinical Trial Update: Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating candesartan for effects on carbohydrate metabolism in obese subjects with glucose intolerance has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance
• Obesity

Drugs mentioned

• Candesartan (candesartan)

Snippet

Sponsor: Fundación Cardiovascular de Colombia | Conditions: Glucose Intolerance, Obesity | Phase 4 | Status: TERMINATED